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Introduction: The need for intubation after a noninvasive ventilation (NIV) failure is frequent in the pediatric
intensive care unit (PICU). One reason is patient-ventilator asynchrony during NIV. Neurally adjusted ventilatory assist
(NAVA) is a mode of ventilation controlled by the patient’s neural respiratory drive. The aim of this study was to
assess the feasibility and tolerance of NIV-NAVA in children and to evaluate its impact on synchrony and respiratory
effort.
Methods: This prospective, physiologic, crossover study included 13 patients requiring NIV in the PICU of
Sainte-Justine’s Hospital from October 2011 to May 2013. Patients were successively ventilated in conventional NIV
as prescribed by the physician in charge (30 minutes), in NIV-NAVA (60 minutes), and again in conventional NIV
(30 minutes). Electrical activity of the diaphragm (EAdi) and airway pressure were simultaneously recorded to assess
patient-ventilator synchrony.
Results: NIV-NAVA was feasible and well tolerated in all patients. One patient asked to stop the study because of
anxiety related to the leak-free facial mask. Inspiratory trigger dys-synchrony and cycling-off dys-synchrony were
significantly shorter in NIV-NAVA versus initial and final conventional NIV periods (both P <0.05). Wasted efforts were
also decreased in NIV-NAVA (all values expressed as median and interquartile values) (0 (0 to 0) versus 12% (4 to 20)
and 6% (2 to 22), respectively; P <0.01). As a whole, total time spent in asynchrony was reduced to 8% (6 to 10) in
NIV-NAVA, versus 27% (19 to 56) and 32% (21 to 38) in conventional NIV before and after NIV-NAVA, respectively
(P =0.05).
Conclusion: NIV-NAVA is feasible and well tolerated in PICU patients and allows improved patient-ventilator
synchronization. Larger controlled studies are warranted to evaluate the clinical impact of these findings.
Trial registration: ClinicalTrials.gov NCT02163382. Registered 9 June 2014.Introduction
Respiratory failure is one main reason for admission to
the pediatric intensive care unit (PICU) [1]. Mechanical
ventilation-related complications occur in 40% of patients
[2,3]. Noninvasive ventilation (NIV) aims to minimize
those complications while supporting the patient’s breath-
ing [4,5]. However, NIV failure requiring intubation occurs* Correspondence: lducharmecrevier@gmail.com
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article, unless otherwise stated.in 19% to 45% of children [6-9] and is associated with a
prolonged PICU stay [8-10]. The inability of the ventilator
to detect the patient’s breathing efforts crucially limits the
efficiency of NIV [11,12]. Patient-ventilator synchroniza-
tion is critical to reduce the work of breathing [13] and to
achieve successful NIV. Obtaining an optimal synchrony
during pediatric NIV is a challenge [11]. The presence of
leaks at the patient-mask interface, the small tidal volume,
and the agitation of the patient impair the detection of the
patient breathing effort. Therefore, CPAP (continuous
positive airway pressure) is the NIV modality most oftened Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ventilation does not seem to offer any advantage [11].
Neurally adjusted ventilatory assist (NAVA) is a
mechanical ventilation modality in which the ventilator
assists the patient breath in proportion to and in syn-
chrony with the electrical activity of the diaphragm
(EAdi) [14]. EAdi is a fast and accurate reflection of
phrenic nerve activity arising from central respiratory
centers [15]. Six pediatric studies showed improved
patient-ventilator interaction with NAVA delivered via
endotracheal tube [12,16-20]. As synchronization in NAVA
is independent of pressure or flow trigger and independent
of leaks [21,22], NAVA has a strong potential to increase
NIV efficiency. Few studies have evaluated NAVA in
pediatric noninvasive conditions. A preliminary study
conducted in six postsurgery children tends to confirm
this potential [23].
The main objective of this study is to evaluate the
feasibility and tolerance of NIV-NAVA in children
treated for respiratory failure of different etiologies in
PICU. The secondary objectives are to compare the syn-
chrony and the mean EAdi, as a reflection of patient work
of breathing, during conventional NIV and NIV-NAVA.
We hypothesized that NIV-NAVA is feasible, improves
patient-ventilator synchrony in children compared with
conventional NIV, and therefore reduces the patient’s
effort.
Methods
This is a prospective, physiological, crossover study com-
paring NIV-NAVA versus conventional NIV in children
admitted to the PICU for respiratory failure. This study
was conducted from October 2011 to May 2013 in
the PICU of Sainte-Justine’s Hospital. The protocol
was approved by the Ethics Committee of Sainte-Justine
Research center (reference 3388). Written informed con-
sent was obtained from the parents or legal tutors. This
study follows CONSORT recommendations.
Study population
Children older than 3 days and younger than 18 years
with respiratory failure, expected to require NIV for
more than 6 hours, were eligible. Patient screening was
done on a daily basis on weekdays by research staff. The
exclusion criteria were (a) contraindication to the place-
ment of a new nasogastric tube; (b) hemodynamic in-
stability requiring dopamine ≥5 μg/kg/min, epinephrine,
norepinephrine, or dobutamine; (c) severe respiratory in-
stability requiring imminent intubation, according to the
attending physician, or FiO2 > 60%, or PaCO2 > 80 mm
Hg on blood gas in the last hour; (d) cardiac patient in
the postoperative course; e) all patients without nasogas-
tric tube, as adding a tube for EAdi recording would
represent adding an intervention in their care; and (f )absence of parent or tutor for consent. Patients for
whom limitation of life-support treatment was discussed
were also excluded.
As per these exclusions, we selected a pediatric intensive
care population critically ill from a respiratory stand-
point, with NIV and nasogastric tube needs for more
than 6 hours.Study protocol
After enrollment, a specific nasogastric tube equipped
with miniaturized electrodes (NAVA catheter, 6, 8, or 12
Fr; Maquet, Solna, Sweden) was installed, by using
the “catheter positioning” screen on the Servo I ventilator
(v 6.0; Maquet). Patients were initially studied on conven-
tional NIV as per their prestudy settings for 30 minutes,
then converted to NIV-NAVA for 60 minutes, and finally
returned to conventional NIV for 30 minutes.Conventional and NIV-NAVA management
During both conventional NIV periods (before and after
NIV-NAVA), the parameters were set as prescribed be-
fore the study. The management of NIV, the choice of
the ventilator, and that of the airway interface were not
guided by written protocol. NIV was always delivered
with a ventilator equipped with specific NIV algorithm.
With the Servo-I, we usually use the infant mode in chil-
dren smaller than 10 kg.
For the NAVA period, the patient was switched to a
Servo I ventilator. Positive end expiratory pressure
(PEEP) and FiO2 were not modified. For patient previ-
ously ventilated with two levels of pressure, the NAVA
level was initially determined to achieve the same peak
inspiratory pressure as in the conventional mode. For a
patient previously on CPAP, the NAVA level was set to
achieve a minimal level of respiratory support (5 cm
H2O). During the first 30 minutes, the NAVA level could
be adjusted based on the respiratory status, to aim for
respiratory rate ≤40/minute and ≥12/minute, minimizing
respiratory efforts, and to compensate for air leaks when
resulting delivered pressure was low (>3 cm H2O).
The NAVA level was kept constant during the last 30
minutes of the NAVA period. During the entire study,
settings modifications by caregivers were permitted and
documented.Data acquisition and measurements
Baseline patient characteristics, cause and modality of
NIV, PIM 2 [24], and PELOD l [25] scores were collected
prospectively. SpO2, FiO2, ventilatory settings, and heart
rate were recorded throughout the study period. EAdi and
airway pressure (Pvent) were simultaneously recorded, as
previously described [17,26].
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Feasibility was assessed by the ability to obtain a correct
EAdi signal (compatible with NAVA ventilation), the
percentage of time spent in NIV-NAVA mode, and NIV-
NAVA interruption. Tolerance was evaluated on the re-
spiratory rate, saturation, FiO2, and EAdi.
Safety guidelines
To provide safety guidelines, the study protocol had
termination criteria including (a) decrease of SpO2 <
92% with FiO2 > 60% for more than 5 minutes; (b) car-
diac rate >180/minute for >10 minutes; (c) respiratory
rate >60/minute for more than 10 minutes; (d) uncon-
trolled agitation; or (e) intolerance suspected by the at-
tending physician.
Asynchrony analysis
The last 10 minutes of each period were analyzed. The
following asynchrony parameters were analyzed: inspira-
tory trigger dys-synchrony, cycling-off dys-synchrony,
and incidence of ineffective efforts and of autotriggered
breaths. The total time spent in asynchrony was calculated
as the cumulative time spent in each asynchrony form
throughout the whole recording time.
The following definitions were used for patient-ventilator
interaction [27,28]: (a) inspiratory trigger dys-synchrony:
time between the beginning of neural inspiration and the
ventilator pressurization; (b) cycling-off dys-synchrony:
time lag between the end of neural inspiration activity
(70% of peak EAdi) and the end of the inspiratory
pressure assistance by the ventilator. The cycling-off
dys-synchronies are reported as absolute values as
cycling-off dys-synchronies usually have a wide distribu-
tion of values with positive or negative values [17,29]; (c)
ineffective effort: neural breath not assisted by the venti-
lator; (d) autotriggered breath: initiation of mechanical
assist by the ventilator without an inflection of EAdi. The
four types of events were detected breath-by-breath with
semiautomatic analysis (one automatic step followed
by a manual verification) of EAdi and airway pressure
waveforms, comparing the neural timing and the ven-
tilator timing [30]. The inspiratory and cycling-off
dys-synchrony can be positive (that is, the ventilator
action is delayed compared with EAdi) or negative
(that is, the ventilator action is premature in relation
to EAdi). The ineffective efforts are expressed in per-
centage of neural cycles and the autotriggered breaths
are expressed in percentage of ventilator breaths.
These parameters were measured for all patients dur-
ing NIV-NAVA period and during conventional NIV
periods for patients on the bilevel type of conven-
tional NIV. The total time spent in asynchrony was
calculated as the cumulative time spent in each asyn-
chrony form throughout the whole recording time.This global percentage was chosen rather than the Asyn-
chrony Index described by Thille et al. [27] because in-
spiratory and cycling-off dys-synchronies are particularly
important in the pediatric population. CPAP periods were
not included in synchrony analysis.
To evaluate objectively the ventilatory effort, mean
EAdi was calculated as the area under the curve for the
entire period of NIV. Two periods (one in initial NIV
and one in NIV-NAVA) were excluded from EAdi ana-
lysis because of technical problems.
Statistical analysis
Data are reported as median (interquartile range), unless
otherwise specified. Continuous variables were com-
pared between the three periods by using the nonpara-
metric Friedman test and the Wilcoxon Signed-Rank
Test for post hoc intergroup analysis. Patients in whom
CPAP was used during conventional NIV were excluded
from the statistical analysis of asynchrony parameters.
Level of significance was set to P <0.05.
In this convenience sample, inclusion of 15 patients
was planned to attempt to represent the PICU popula-
tion in this feasibility study.
Results
During the study period, 118 NIV episodes were
screened for possible inclusion. Ten patients did not
meet the inclusion criteria, 75 patients had exclusion cri-
teria, and for 18 patients, material or personnel for the
study was not available (Figure 1). In total, 15 patients
were enrolled in the study. Two included patients could
not be recorded because of personnel or material un-
availability. Thirteen patients were included in the ana-
lysis. The patient’s characteristics are summarized in
Table 1. The median age was 42 (2 to 109) months. Eight
patients were admitted for pneumonia or bronchiolitis.
Six patients were taking NIV to facilitate extubation.
The ventilator settings are described in Table 2. At base-
line, three patients were on CPAP, five on PSV, and five
on PCV. Three types of interface were used: four naso-
pharyngeal tubes, three nasal masks, and six nasobuccal
masks. The conventional NIV was delivered with Servo I
(n = 5), BiPAP version (n = 1), VPAP III (n = 1), Trilogy
(n = 3), or babylog 8000 (n = 3).
It was possible to obtain an EAdi signal and to provide
NIV-NAVA in all patients. No apnea, reversion to backup
ventilation, or interruption of NIV-NAVA was observed,
despite patient manipulation or sedation. The study was
interrupted prematurely for one patient (patient 4). This
adolescent was used to chronic NIV with a nasal
mask at home during the night, and a change of mask
was required for the purpose of the study. During the
initial conventional NIV period, he was ventilated by
using pressure-control mode, with a PEEP of 6 cm H2O,
Figure 1 Patients’ flow charts.
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per minute, and FiO2 of 21%, resulting in mean EAdi of
3.3 μV, which increased to 7.5 μV during the NAVA
period. The patient argued that the new nasobuccal leak-
free mask caused him anxiety in both modes, which ultim-









1 M 1.5 4.5 0.3 10 No
2 F 2.5 2.3 1.5 2 Yes
3 M 42 15 4.3 1 Yes
4 M 151 24.7 0.6 3 Yes
5 M 190 55 0.5 3 Yes
6 M 61.5 21.2 0.3 1 No
7 M 142 20 0.3 3 Yes
8 M 2 4.8 38.5 13 Yes
9 F 8 6.8 0.2 0 No
10 M 76 14.8 0.3 0 No
11 F 46 15.4 0.4 0 No
12 M 1 3.1 0.6 0 No
13 F 1 3.3 0.31 0 No
PICU, pediatric intensive care unit; NIV, noninvasive ventilation; EAdi, electrical activ
pressure; PSV, pressure support ventilation; PCV, pressure control ventilation.the study at the end of the NAVA period. No side effects
were reported.
A median of 380 (295 to 617) pneumatic-triggered
breaths per period per patient were analyzed. As illustrated
in representative patients (Figure 2) and for the entire










Postop scoliosis PCV 19
Postop scoliosis PCV 167
Pneumonia PSV 12
Postop scoliosis PSV 7
Heart failure CPAP 22
Bronchiolitis PSV 25




ity of the diaphragm; M, male; F, female; CPAP, continuous positive airway
Table 2 Noninvasive ventilation parameters
Initial conventional NIV period NIV-NAVA period Final conventional NIV period
NIV settings
NIV mode 3 CPAP, 5 PSV, 5 PCV 13 NAVA 3 CPAP, 5 PSV, 5 PCV
FiO2 (%) 35 (27-40) 30 (25-35) 33 (30-36)
Set respiratory rate (n/min) 14 (10-19) – 14 (10-19)
PEEP (cm H2O) 6 (5-7) 6 (5-7) 6 (5-7)
Pressure support (cm H2O) 10 (7-12) – 10 (7-12)
NAVA gain level (cm H2O/μV) – 0.4 (0.3-0.6) –
Measured respiratory parameters
Respiratory rate (per minute) 41 (31-64) 41 (31-61) 39 (29-63)
Mean airway pressure (cm H2O) 12.3 (8.8-14.8) 10.6 (8.1-14.2) 11.9 (9.2-14.1)
Peak EAdi (μV) 13.4 (6.8-35.1) 15.1 (10.0-27.9) 16.1 (7.2-34.4)
End-expiration EAdi (μV) 1.1 (0.3-3.3) 1.2 (0.8-2.8) 1.7 (0.3-3.3)
Mean EAdi (μV) 7.0 (2.2-16.2) 7.6 (6.2-11.4) 7.7 (2.3-16.6)
All values expressed as median and interquartile values. NIV, noninvasive ventilation; CPAP, continuous positive airway pressure; PSV, pressure support ventilation,
PCV, pressure control ventilation.
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As detailed in Table 3, the total time spent in asynchrony
was 8% (6% to 10%) in NAVA, versus 27% (19% to 56%),
and 32% (21% to 38%), in conventional NIV before and
after periods, respectively (P =0.05). Inspiratory trigger dys-
synchrony, cycling-off dys-synchrony, and wasted efforts
were significantly reduced in NIV-NAVA (P <0.05; P <0.05,
and P <0.01, Table 3 and Figure 3). The difference for auto-
triggering did not reach significance.
The peak and minimal EAdi values were similar in all
three periods (P =0.3 and P =0.9, Table 3). The mean
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Figure 2 Example of synchronization between ventilator pressure (PVEN
under NIV. (A) a 1-month-old infant admitted for bronchiolitis on noninvasiv
postoperative patient with scoliosis on noninvasive Pressure Control (PC) and
autotriggered breaths during conventional NIV.periods. However, the evolution of mean EAdi differed,
depending on baseline EAdi, as illustrated in Figure 4.
Patients with low baseline mean EAdi (area under the
curve below 10 μV, Patients 4, 5, 7, and 13) showed an
increase of mean EAdi during NIV-NAVA, whereas
patients with higher mean baseline EAdi showed a
decrease of EAdi in NAVA.
Discussion
The current study provides evidence for the feasibility
and tolerance of NIV-NAVA in children. Furthermore,
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T) and electrical activity of the diaphragm (EAdi) in two children
e Pressure Support Ventilation (PSV) and in NIV-NAVA. (B) A 12-year-old


























Figure 3 Inspiratory dys-synchrony (ms), cycling-off dys-synchrony (ms), ineffective efforts (%) and autotriggered breaths (%) in initial
conventional NIV, NIV-NAVA, and final conventional NIV. CPAP periods (n = 3) were not included in synchrony evaluation of conventional
NIV periods (they could be considered as 100% wasted efforts). *P≤ 0.05 and ┼P < 0.01.
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ventilator asynchrony. No difference in patient effort was
found among NIV conditions as a whole, even if it tended
to decrease in patients with high baseline EAdi.
As dys-synchrony may be associated with negative im-
pact on outcome [27], optimization of patient-ventilator
synchrony is probably necessary for NIV success. NIV is
increasingly used in PICU [5,31,32]. However, NIV fail-
ure is relatively frequent (19% to 45%) [6-9,28,32] and is
associated with a longer length of stay than that in pa-
tients with invasive ventilation only [5]. To decrease NIV
failure, progress of NIV technology is therefore crucial.
CPAP currently represents the NIV modality of choice for
infants in most PICUs, as bilevel support did not prove
any advantage over CPAP [11,33], probably because of the
lack of synchronization. Essouri et al. [11] described the
poor synchrony during conventional NIV in children with
upper airway obstruction. Two thirds of breaths were not
detected, trigger delays were long (300 ms), and cycling-
off was not synchronized [11].
During invasive pediatric ventilation, our team [17] and
others [12,19,22] demonstrated the efficacy of NAVA toTable 3 Patient–Ventilator asynchrony parameters in the thre
Initial conventional NIV period
Inspiratory trigger synchrony (ms) 164 (137-217)
Absolute cycling-off asynchrony (ms) 104 (51-257)
Wasted efforts (% neural breath) 12 (4-20)
Autotriggering (% ventilator breath) 2 (0-22)
Asynchrony time (% total time) 27 (19-56)
All values expressed as median and interquartile values.
aFriedman test. The statistical analyses were restricted to the 10 patients in whom c
bSignificant difference between Initial conventional and NIV-NAVA and between NIVimprove patient-ventilator synchrony. The present study
confirms that NAVA also improves patient-ventilator
interaction in pediatric NIV conditions. NIV-NAVA did
significantly reduce ineffective efforts and dys-synchrony
in trigger and cycling-off. The results agree with those of
previous adult studies on NIV-NAVA, demonstrating a
decrease in premature and delayed cycling, abolishment of
ineffective effort, reduction of asynchrony events, and a
preserved CO2 clearance [34-36]. Our results are also
concordant with the only pediatric study of NIV-NAVA,
reported by Vignaux et al. [23], which documented a sig-
nificant decrease in ineffective efforts and overall asyn-
chrony index in six postsurgery patients with respiratory
distress after extubation. A previous preliminary study by
Beck et al. [22] showed an adequate synchrony in NIV-
NAVA in five premature babies with low birth-weight,
despite important leaks.
The present study confirms the benefit of NIV-NAVA
on synchrony in a group of critically ill children with dif-
ferent underlying diseases, different ages and weights
and different baseline NIV settings, reflecting the actual
practice in PICUs.e NIV conditions
NIV-NAVA period Final conventional NIV period P valuea
71 (60-106) 190 (168-222) 0.02b
24 (14-38) 86 (33-156) 0.02b
0 (0-0) 6 (2-22) <0.01b
0 (0-1) 4 (0-26) 0.34
8 (6-10) 32 (21-38) 0.05
onventional NIV was not CPAP.





































Baseline EAdi (µV)  
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Figure 4 Comparison of mean EAdi during conventional and NAVA NIV. (A) Individual mean EAdi during conventional NIV and NIV-NAVA
periods. (B) The change in mean EAdi observed from conventional NIV to NIV-NAVA period, according to initial EAdi.
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important components of asynchrony in the pediatric
population. Children present short inspiratory and ex-
piratory times and delays to activate or inactivate the as-
sistance have a higher proportional significance [17,26].
In our study, these delays contributed markedly to asyn-
chrony during conventional NIV. This asynchrony time
was increased by the occurrence of wasted efforts and
autocycled breaths. Of note, the total time spent in asyn-
chrony in conventional NIV was similar in younger (≤2
years old) and older children in the present study. In
NIV-NAVA, most of these asynchrony events improved,
and the total time spent in asynchrony decreased to 8%.
Of note, some asynchrony remained in NIV-NAVA, mainly
inspiratory trigger delay and cycling-off asynchrony, both
of brief duration (71 and 24 ms, respectively). We were not
able to record the type of trigger that was activated during
NAVA ventilation, so the asynchrony parameters during
NAVA include both breaths triggered by the EAdi and the
pneumatic triggers. Autotriggered breaths in NAVA may
be explained by the pneumatic triggering, which can be ac-
tivated, besides neural triggering, on a first-come, first-
served principle.
Another potential interest of synchrony is the im-
proved airway control. Studies in lambs have shown that
conventional NIV is associated with glottal constriction
during the inspiratory assist [37]. The authors speculated
that the rapid insufflating flow could trigger a reflex
constriction of the glottal constrictor muscle. Laryngeal
constriction was not observed during NIV-NAVA [38]. In
healthy adults, hyperventilation can also result in glottis
narrowing and decrease in diaphragmatic activity, whereas
normal spontaneous breathing is associated with glottis
widening [39]. During NAVA, the inspiratory assistance is
in proportion to the patient respiratory drive, and the
normal respiratory pattern of the airway and respiratory
muscles may be better respected.Our study reinforces the feasibility of NIV-NAVA in
the PICU. In clinical conditions, including the use of
sedation, nursing care, physical examination and agitation,
there was no interruption related to NAVA technology,
and no reversal to backup ventilation. NIV-NAVA is not
associated with an increase of invasiveness, as a nasogas-
tric tube is used in most children during NIV. The only
premature interruption seemed to be related to anxiety
from a leak-free mask, although this was a subjective per-
ception, and we cannot rule out an effect of the NIV algo-
rithm or flow. Any NIV mode has a risk of discomfort
[40], and mask failure is close to 15% [41].
The improvement in synchrony may have clinical ben-
efits. Asynchrony has been associated with discomfort,
inadequate unloading of work of breathing, and longer
ventilatory support [27]. We did not evaluate the impact
on discomfort, and the study was not designed to evalu-
ate the NIV success rate. We did not confirm that NIV-
NAVA could decrease the mean EAdi, a reflection of the
work of breathing. This can be partially explained by the
fact that four patients on bilevel pressure ventilation had
very low EAdi at baseline, suggesting they may be over-
assisted during conventional NIV, a condition that has
previously been reported in healthy adults, although
with different asynchrony patterns [39]. Two of them
were in a postoperative state with NIV conducted as a
prophylactic measure after extubation. The two other
patients (one with heart failure and one with bronchio-
litis) were recovering at the time of recording and exhib-
ited very little respiratory efforts. In these conditions, an
increase in EAdi during NAVA is expected, because of
feedback and absence of overassistance in this mode
[42,43]. Contrastingly, all patients with high mean EAdi
(>10 μV) exhibited a decrease in EAdi with NAVA.
Interestingly, these patients had acute respiratory fail-
ure from bronchiolitis (three infants) and pneumonia
(one child).
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the mode of ventilation NAVA may allow the patient to
regulate his or her work of breathing. This also suggests
that future trials that will evaluate the clinical benefits of
NAVA should focus mostly on patients in whom a clear
benefit is expected; this may include particularly patients
with significant respiratory failure (or high EAdi). It is
important to note that the cutoff value of 10 μV is refer-
ring not to peak EAdi but to the mean EAdi. The mean
EAdi (the area under the curve for the entire recording)
was chosen to represent all components of diaphragm
activity (inspiration, expiration, frequency) for the entire
period (and not limited to a selected period). Inspiratory
peak EAdi values in critically ill children have recently
been described by our team [17,18,44], and in the recov-
ery phase, median (interquartile) observed peak EAdi
values were 13 (8 to 21) μV [44], whereas the area under
the curve for EAdi was 6 (2 to 9) μV (unpublished data).
Besides patient’s condition, the setting of NAVA level
also influences EAdi. The NAVA level was adjusted based
on the respiratory status, as in our clinical practice, and a
different NAVA level could have resulted in other EAdi
profiles. In a feasibility study in rabbits, the NAVA level
had to be increased to achieve a similar unloading, as
compared with the pre-extubation condition, mainly be-
cause of major air leaks [21].
Several limitations of the study must be outlined. This
feasibility study included a limited number of patients in
a single PICU, and a majority of NIV-exposed patients
during the period were excluded, thereby limiting ability
to generalize our findings. The population was intentionally
heterogeneous, and representative of various ages and
pathologies. The sample size does not permit to assess dif-
ferences among these groups, but the study results pro-
vide further evidence regarding NAVA feasibility, which
will permit us to prepare and justify for future studies in
these groups. The study included some patients with sig-
nificant distress, but also patients with prophylactic NIV,
in whom few signs of respiratory failure were present. This
may have diminished the power to detect a decrease in
the work of breathing. We included patients on CPAP,
even though no synchrony can be analyzed, because CPAP
is the primary NIV option for infants in our PICU. We
therefore did not want to exclude those patients from
this evaluative study. The study duration was limited to a
2-hour period, to limit period effect. Future longer-term
evaluation is therefore necessary. We did not evaluate the
impact of the NIV mode on the delivered pharyngeal pres-
sure or tidal volumes, but the EAdi evolution provided
some indications on the work of breathing changes.
Conclusion
NIV-NAVA is feasible and well tolerated in critically ill
children. It improves patient-ventilator synchrony whencompared with conventional NIV. Further studies are
warranted to evaluate the clinical impacts of NIV-NAVA,
especially on NIV success, ventilator-support duration,
and comfort.
Key messages
 Asynchrony occurs during almost a third of the
time during pediatric conventional noninvasive
ventilation.
 Noninvasive NAVA allows us to support the
ventilation in synchrony with patient efforts.
 The potential of NAVA to improve noninvasive
ventilation success must be studied in children.
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